India considering Pfizer's request for vaccine indemnity, govt advisor says
"We are engaged with Pfizer because they have indicated availability of ... certain volume of vaccines, in the coming months, possibly starting in July," V K Paul told a news conference on Thursday
A woman holds a small bottle labeled with a "Coronavirus Covid-19 Vaccine" sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic/File Photo
India is considering Pfizer's request to grant it indemnity from costs relating to severe vaccine side-effects, a government advisor said on Thursday, adding that the company had signalled availability of its Covid-19 shot, possibly from July.
"We are engaged with Pfizer because they have indicated availability of ... certain volume of vaccines, in the coming months, possibly starting in July," V K Paul told a news conference on Thursday.
Keep updated, follow The Business Standard's Google news channel
